US Stock MarketDetailed Quotes
SNTI Senti Biosciences
- 2.1500
- -0.1800-7.73%
Close Nov 15 16:00 ET
- 2.2000
- +0.0500+2.33%
Post 17:43 ET
9.87MMarket Cap-137P/E (TTM)
2.4700High2.1500Low10.05KVolume2.4700Open2.3300Pre Close23.20KTurnover0.35%Turnover RatioLossP/E (Static)4.59MShares7.430052wk High0.62P/B6.27MFloat Cap1.520152wk Low--Dividend TTM2.92MShs Float105.4000Historical High--Div YieldTTM13.73%Amplitude1.5200Historical Low2.3070Avg Price1Lot Size
Senti Biosciences Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 38.98%-8.35M | 28.35%-11.68M | -50.15%-52.4M | 21.86%-7.04M | -51.73%-15.38M | -140.12%-13.68M | -62.08%-16.3M | -0.75%-34.9M | 24.77%-9.01M | -15.12%-10.14M |
| Net income from continuing operations | 40.08%-11.2M | 35.31%-12.11M | -22.05%-71.06M | -2.60%-18.7M | 10.19%-14.94M | -61.85%-18.7M | -58.55%-18.72M | -5.25%-58.22M | -67.11%-18.22M | -45.89%-16.64M |
| Operating gains losses | ---- | ---- | -1,596.04%-21.86M | --0 | ---- | ---- | ---- | ---1.29M | --0 | --0 |
| Depreciation and amortization | 21.14%1.47M | 57.27%1.46M | 38.49%5.43M | 56.14%1.47M | 76.04%1.82M | 29.52%1.21M | -8.02%929K | 30.23%3.92M | -8.70%944K | 18.23%1.03M |
| Other non cash items | 3,073.17%3.66M | -2,551.69%-2.36M | 45.90%-5.2M | 176.02%799K | -2,062.03%-5.79M | ---123K | ---89K | -165.21%-9.61M | ---1.05M | --295K |
| Change In working capital | 171.02%2.39M | 104.34%70K | -66.45%4.67M | 17.39%5.98M | -120.19%-583K | -84.97%880K | -2,543.94%-1.61M | 2,160.81%13.9M | 278.83%5.1M | 163.99%2.89M |
| -Change in receivables | -183.42%-166K | 115.56%21K | -609.16%-929K | 401.72%1.16M | -690.11%-2.16M | 239.16%199K | -354.72%-135K | 66.84%-131K | 564.00%232K | ---273K |
| -Change in prepaid assets | 948.26%4.21M | 1,015.17%3.68M | 468.20%4.79M | 525.98%3.35M | 410.75%1.45M | 140.57%402K | -5.51%-402K | 20.71%-1.3M | 977.05%535K | 42.02%-465K |
| -Change in payables and accrued expense | -266.94%-616K | -63.28%-2.56M | -80.99%426K | 75.15%1.16M | -59.18%467K | -81.68%369K | 0.70%-1.57M | 14.51%2.24M | 130.34%660K | -55.54%1.14M |
| -Change in other current liabilities | -742.48%-983K | -207.26%-946K | -96.57%484K | -87.53%370K | -128.64%-921K | -97.23%153K | -63.61%882K | 1,342.66%14.13M | 1,920.86%2.97M | 1,407.32%3.22M |
| -Change in other working capital | 73.66%-64K | 67.60%-127K | 89.35%-110K | -108.29%-58K | 179.43%583K | 55.49%-243K | 13.47%-392K | -156.39%-1.03M | 275.00%700K | -70.30%-734K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 38.98%-8.35M | 28.35%-11.68M | -50.15%-52.4M | 21.86%-7.04M | -51.73%-15.38M | -140.12%-13.68M | -62.08%-16.3M | -0.75%-34.9M | 24.77%-9.01M | -15.12%-10.14M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 99.84%-15K | 136.70%30.08M | 100.21%101K | 248.88%21.14M | 262.80%18.33M | -28.69%-9.5M | -1,378.60%-81.96M | -1,132.57%-49.12M | -1,423.71%-14.2M |
| Net PPE purchase and sale | --0 | 99.77%-15K | 71.16%-11.93M | 101.18%101K | 86.92%-1.86M | 67.42%-3.67M | 11.83%-6.51M | -646.42%-41.37M | -114.13%-8.53M | -1,423.71%-14.2M |
| Net investment purchase and sale | --0 | --0 | 203.51%42.01M | --0 | --23M | --22M | ---2.99M | ---40.59M | ---40.59M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | 99.84%-15K | 136.70%30.08M | 100.21%101K | 248.88%21.14M | 262.80%18.33M | -28.69%-9.5M | -1,378.60%-81.96M | -1,132.57%-49.12M | -1,423.71%-14.2M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | -99.34%779K | -36.53%556K | 95.26%-23K | -99.76%281K | 92.31%-35K | 73.23%118.55M | 3,708.70%876K | -199.59%-485K |
| Net issuance payments of debt | --0 | --0 | -102.09%-108K | ---23K | ---23K | -100.52%-27K | ---35K | --5.18M | --0 | --0 |
| Net common stock issuance | ---- | ---- | -29.67%512K | ---- | ---- | ---- | ---- | --728K | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | -44.20%375K | -55.63%67K | --0 | ---- | ---- | -55.20%672K | 277.50%151K | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 658,782.35%111.98M | ---3K | ---485K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | -99.34%779K | -36.53%556K | 95.26%-23K | -99.76%281K | 92.31%-35K | 73.23%118.55M | 3,708.70%876K | -199.59%-485K |
| Net cash flow | ||||||||||
| Beginning cash position | -21.05%27.75M | -35.32%39.45M | 2.86%60.99M | -61.24%45.83M | -71.98%40.09M | -15.09%35.15M | 2.86%60.99M | 91.05%59.29M | 57.18%118.24M | 69.35%143.06M |
| Current changes in cash | -269.03%-8.35M | 54.73%-11.7M | -1,369.99%-21.54M | 88.86%-6.38M | 123.12%5.74M | -95.14%4.94M | -44.38%-25.84M | -94.00%1.7M | -259.30%-57.25M | -168.35%-24.82M |
| End cash Position | -51.59%19.41M | -21.05%27.75M | -35.32%39.45M | -35.32%39.45M | -61.24%45.83M | -71.98%40.09M | -15.09%35.15M | 2.86%60.99M | 2.86%60.99M | 57.18%118.24M |
| Free cash flow | 51.89%-8.35M | 48.72%-11.7M | 15.52%-64.43M | 59.86%-7.04M | 29.17%-17.24M | -2.29%-17.34M | -30.80%-22.81M | -89.83%-76.27M | -9.92%-17.54M | -149.94%-24.34M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data